0001209191-22-010485.txt : 20220216
0001209191-22-010485.hdr.sgml : 20220216
20220216214003
ACCESSION NUMBER: 0001209191-22-010485
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220214
FILED AS OF DATE: 20220216
DATE AS OF CHANGE: 20220216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aftab Blake
CENTRAL INDEX KEY: 0001886986
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38359
FILM NUMBER: 22645480
MAIL ADDRESS:
STREET 1: C/O ADICET BIO, INC.
STREET 2: 200 CLARENDON STREET, FLOOR 6
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adicet Bio, Inc.
CENTRAL INDEX KEY: 0001720580
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813305277
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 CLARENDON STREET
STREET 2: FLOOR 6
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-482-2333
MAIL ADDRESS:
STREET 1: 200 CLARENDON STREET
STREET 2: FLOOR 6
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: resTORbio, Inc.
DATE OF NAME CHANGE: 20171024
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-14
0
0001720580
Adicet Bio, Inc.
ACET
0001886986
Aftab Blake
C/O ADICET BIO, INC.
200 CLARENDON STREET, FLOOR 6
BOSTON
MA
02116
0
1
0
0
Chief Scientific Officer
Common Stock
2022-02-14
4
A
0
16000
0.00
A
58436
D
Common Stock
2022-02-14
4
F
0
5533
14.27
D
52903
D
The Reporting Person was issued 80,000 Restricted Stock Units ("RSUs") on October 12, 2021, as previously reported on a Form 4 filed by the Reporting Person on October 13, 2021. Each RSU represents a contingent right to receive one share of common stock. A total of 32,000 of the RSUs shall vest in two (2) annual installments of 20% of the shares vesting, with the first tranche vesting on October 12, 2022 and the second tranche vesting on October 12, 2023. A total of 48,000 of the RSUs shall vest upon achievements of specific milestones outlined in the Reporting Persons Restricted Stock Unit Agreement. On February 14, 2022, upon the occurrence of the second performance milestone, 16,000 of the RSUs vested. The RSUs may be settled only by delivering shares of common stock, and thus, the grant is being reported in Table I as allowed per SEC guidance.
/s/ Nick Harvey, Attorney-in-Fact
2022-02-16